|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2007-12-14
|
|
pubmed:abstractText |
To investigate the pharmacokinetic profile of a single 100-mg oral dose of sitaxsentan, a selective endothelin type A receptor antagonist, in subjects with normal and impaired renal function.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1365-2125
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
64
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
733-7
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17635499-Adolescent,
pubmed-meshheading:17635499-Adult,
pubmed-meshheading:17635499-Aged,
pubmed-meshheading:17635499-Female,
pubmed-meshheading:17635499-Humans,
pubmed-meshheading:17635499-Isoxazoles,
pubmed-meshheading:17635499-Kidney Diseases,
pubmed-meshheading:17635499-Male,
pubmed-meshheading:17635499-Metabolic Clearance Rate,
pubmed-meshheading:17635499-Middle Aged,
pubmed-meshheading:17635499-Receptor, Endothelin A,
pubmed-meshheading:17635499-Thiophenes
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
The pharmacokinetic profile of sitaxsentan, a selective endothelin receptor antagonist, in varying degrees of renal impairment.
|
|
pubmed:affiliation |
Clinical Pharmacology Unit, University of Edinburgh, Queen's Medical Research Unit, Edinburgh, UK. bean.dhaun@ed.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
